Commentary on “Conditional survival of patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A population-based study.” Harshman LC, Xie W, Bjarnason GA, Knox JJ, MacKenzie M, Wood L, Srinivas S, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Agarwal N, Kollmannsberger C, North S, Rini BI, Heng DY, Choueiri TK, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
2013 ◽
Vol 31
(1)
◽
pp. 127-128
◽
2012 ◽
Vol 13
(9)
◽
pp. 927-935
◽
2015 ◽
Vol 16
(3)
◽
pp. 293-300
◽
2013 ◽
Vol 14
(2)
◽
pp. 141-148
◽
2018 ◽
Vol 200
(5)
◽
pp. 989-995
◽
2014 ◽
Vol 12
(4)
◽
pp. e127-e131
◽
Keyword(s):
2021 ◽
Vol 47
(2)
◽
pp. 333-349
◽
2011 ◽
Vol 18
(10)
◽
pp. 2988-2996
◽
2017 ◽
Vol 15
(3)
◽
pp. e397-e404
◽